Laura Samá

🇮🇹 General Surgeon | Sarcoma Melanoma and Rare Tumor Surgery Unit | IRCCS
Humanitas Research Hospital (Milan) |
Curie Institute (Paris) |

[ESMO - Eur. Oncology @myESMO]

📣 Abstract submission is OPEN! Join us at the ESMO Sarcoma and Rare Cancers Congress 2026 in Lugano, 12–14 March.

⏰ Abstract submission ddl: 9 December, 21:00 CET.

👉 Don’t miss your chance to present at this global oncology forum! #ESMORareCancers26

🔗 https://t.co/PULO1wKlT5

[SICO Sarcoma Social @oncoteamsarcoma]

Follow us! @oncoteamsarcoma

[SICO Sarcoma Social @oncoteamsarcoma]

🔎 Demicco Score in Solitary Fibrous Tumors (SFT):
A practical, pathology-based tool to assess metastatic risk in primary SFTs.
3-variable (2012): Size, Mitoses, Age
4-variable (2017): + Necrosis
🧠 Do you use it in your practice? #Sarcoma #SFT #OncoPath

[European Society of Surgical Oncology (ESSO) @ESSOnews]

🚨 Opportunity for early-career surgical oncologists!
Apply for the SSO-ESSO ICDE 2026 and:
✈️ Attend #SSO2026 in Phoenix
🏥 Join a 1-week US clinical observership
🤝 Get matched with a long-term SSO mentor
🔗 Apply by 30 Sept 2025: https://t.co/a4tXErKpTs

[CTOS @ctosociety]

We're launching a new series #fromCTOStoSUCCESS to highlight papers based on data presented at #CTOS2024!

🚨New benchmark values for outcomes of comprehensive resection of retroperitoneal liposarcoma! Great effort by @TirottaFabio and @TARPSWG collaborators👏
link below⬇️

[SICO Sarcoma Social @oncoteamsarcoma]

‼️ Pelvic Sarcoma
A Solitary Fibrous Tumor managed at the Sarcoma Surgery Unit, ⁦@HumanitasMilano⁩ (Dir. ⁦@FCMCananzi⁩ ).

#SarcomaSurgery #Teamwork #SICOSarcomaSocial #SurgicalOncology #RareTumors

[SICO Sarcoma Social @oncoteamsarcoma]

For more information:

🔗 https://t.co/s12vVfQ58D

🔗 https://t.co/zHqQ6XKOZU

@WinanvanHoudt @alegronchi
#CancerResearch #Sarcoma #ClinicalTrials #Oncology #Surgery

[SICO Sarcoma Social @oncoteamsarcoma]

Could neoadjuvant chemo reshape RPS treatment?
#STRASS2 is testing if pre-op chemo improves outcomes in high-risk DDLPS & LMS.

A game-changing randomized phase III trial in the making.

🧵👇 Like, Share and Comment!
#SarcomaSurgery #SICOSarcomaSocial #ClinicalTrials

[SICO Sarcoma Social @oncoteamsarcoma]

🚨 #STRASS trial & neoadjuvant RT in RPS: where do we stand?

📚 No ARFS benefit overall
📈 Signals in liposarcoma

Your take on preop RT for low-grade LPS?

👉 Follow @SICOSarcoma for more.
#SarcomaSurgery #RetroperitonealSarcoma @ctosociety @TARPSWG @ItaSarcomaGroup @ESSOnews

[CTOS @ctosociety]

CTOS President @SilviaStacchia is inviting everyone to join the Annual Meeting in Boca Raton and celebrate 30th Anniversary of the Society!

Get ready and prepare your abstracts!
Especially on the #sarcoma of the year 🌟#chondrosarcoma
#CTOS2025 #CTOSTweeTOS

[Dirk Strauss @Dirk_Strauss]

Excellent and comprehensive review on management of retroperitoneal sarcomas. Well done!

[Dario Callegaro @DCalleMD]

Exploring #MIS solutions for #duodenal #GIST? Take a look at our approach to Laparoscopic #Pancreas-Preserving Duodenal Resection: https://t.co/bt1JxdISqU @alegronchi @AnnSurgOncol @FioreDoc @IstTumori @ItaSarcomaGroup @oncoteamsarcoma #surgery #surgicaloncology

[Catherine Sarre @sarresurgeon]

Thrilled to share our latest publication in @AnnSurgOncol Practice Guideline Series: Multidisciplinary management of #retroperitoneal #sarcoma

Full text 🔗: https://t.co/aAMTRMk7iz

Thank you @kencardonaMD @DCalleMD for your incredible partnership and expertise

[SICO Sarcoma Social @oncoteamsarcoma]

📌 Clinical Case 3
This case dives into #neoadjuvant #treatment for retroperitoneal sarcoma.
Why did we opt for #radiotherapy before surgery?
Clue: STRASS trial 👇

🫱 Acknowledgment for imaging: Istituto Oncologico Europeo (IEO), Milan.
#Sarcoma #RPS #SICOSarcomaSocial

[SICO Sarcoma Social @oncoteamsarcoma]

New Q&A session!
All answers are evidence-based!
Must-read papers:

🔗https://t.co/mAsxibLRlJ

🔗https://t.co/XW3hkA5IPF

🔗 https://t.co/czA65FJhuk

[Marco Fiore, MD, FACS, FEBSh @FioreDoc]

Impact and safety of pregnancy on desmoid fibromatosis management in the era of active surveillance. An international multicenter retrospective observational study - European Journal of Cancer https://t.co/mhlIbhPaTC

[SICO Sarcoma Social @oncoteamsarcoma]

Are you following our SICO Sarcoma Social Journal Club?
🙋🙋‍♀️🙋‍♂️If you have any questions or doubts, feel free to leave a comment or send us a DM.
We will address all your questions next week during the Q&A session!

[SICO Sarcoma Social @oncoteamsarcoma]

@GladdyLab @TARPSWG

[SICO Sarcoma Social @oncoteamsarcoma]

@Dirk_Strauss @TARPSWG

[SICO Sarcoma Social @oncoteamsarcoma]

@FioreDoc @TARPSWG